DOCSLIB.ORG

Using a Trillion Points of Data to Deliver Precision Medicine

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Using a Trillion Points of Data to Deliver Precision Medicine Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte MD, PhD Director Institute for Computational Health Sciences Professor of Pediatrics University of California San Francisco, CA Dr. Atul Butte is the Director of the new Institute for Computational Health Sciences (ICHS) at the University of California, San Francisco, and a Professor of Pediatrics. Dr. Butte trained in Computer Science at Brown University, worked as a software engineer at Apple and Microsoft, received his MD at Brown University, trained in Pediatrics and Pediatric Endocrinology at Children's Hospital Boston, then received his PhD from Harvard Medical School and MIT. Dr. Butte has authored nearly 200 publications, with research repeatedly featured in Wired Magazine, the New York Times and the Wall Street Journal. Dr. Butte is also the principal investigator of ImmPort, the archival and dissemination repository for clinical and molecular datasets funded by the National Institute of Allergy and Infectious Diseases. In 2013, Dr. Butte was recognized by the White House as an Open Science Champion of Change for promoting science through publicly available data. Other recent awards include the 2014 E. Mead Johnson Award for Research in Pediatrics, 2013 induction into the American Society for Clinical Investigation, the 2012 FierceBiotech IT “Top 10 Biotech Techies”, and the 2011 National Human Genome Research Institute Genomic Advance of the Month. Dr. Butte is also a founder of three investor-backed data- driven companies: Personalis, providing clinical interpretation of whole genome sequences; Carmenta, discovering diagnostics for pregnancy complications; and, NuMedii, finding new uses for drugs through open molecular data. Annual Quality Congress, Plenary Session, Sunday, October 4, 2015 Using a Trillion Points of Data to Deliver Precision Medicine Objective: Reflect on the power of “big data” and how it will drive healthcare in the 21st century and beyond. Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Conflicts of Interest •Scientific founder and –Genstruct –Northrop Grumman advisory board membership – Tercica – Aptalis Using a Trillion Points of Data to Deliver –Genstruct –Ecoeos – Thomson Reuters –NuMedii –AnshLabs –Intel Precision Medicine – Personalis – Prevendia –SAP –Carmenta – Samsung –SV Angel – Assay Depot •Speakers’ bureau [email protected] • Honoraria for talks Atul Butte, MD, PhD – Lilly – Regeneron –None –Pfizer –Verinata • Companies started by students @atulbutte – Pathway Diagnostics Director, Institute for Computational –Siemens –Carmenta –GeisingerHealth @ImmPortDB –Bristol Myers Squibb – Serendipity Health Sciences –Covance – AstraZeneca –NuMedii – Wilson Sonsini Goodrich & –Roche – Stimulomics University of California, San Francisco Rosati – Genentech – NunaHealth – 10X Genomics – Warburg Pincus –Praedicat –Medgenics –MyTime •Past or present consultancy –GNS Healthcare – Flipora – Lilly – Gerson Lehman Group – Johnson and Johnson – Coatue Management –Roche •Corporate Relationships – NuMedii Kilo Kilo Kilo Mega Mega Giga October 4, 2015 1 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Kilo Kilo Mega Mega Giga Giga Tera Tera Peta Kilo Kilo Mega Mega Giga Giga Tera Tera Peta Peta Exa Exa Zetta Already nearly 1.6 million microarrays publicly‐available! Doubles every 2‐3 years! Butte AJ. Translational Bioinformatics: coming of age. JAMIA, 2008. October 4, 2015 2 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Yes, even a high‐school student can use public data to design a new diagnostic! Preeclampsia: large cause of maternal and fetal death • Incidence • 5‐8% of all pregnancies in the U.S. and worldwide • 4.1 million births in the U.S. in 2009 • Up to 300K cases of preeclampsia annually in the U.S. • Mortality • Responsible for 18% of all maternal deaths in the U.S. • Maternal death in 56 out of every 100,000 live births in US • Neonatal death in 71 out of every 100,000 live births in US • Cost Linda Liu • $20 billion in direct costs in the U.S annually Matt Cooper • Average hospital stay of 3.5 days Marina Sirota Bruce Ling Linda Liu Bruce Ling New markers for preeclampsia Matt Cooper Liu LY, …, XB Ling, Butte AJ. BMC Medicine, 2013. October 4, 2015 3 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD March of Dimes Life Science Need a Data analyzed, Public big data Center for SPARK grant Angels, other diagnostic for diagnostic available Prematurity ($50k) seed investors preeclampsia designed Research ($2 million) Anti‐seizure drug works against a rat model of inflammatory bowel disease Rat colonoscopy Rat with Inflammatory Inflammatory Bowel Disease Bowel Disease After Anti‐seizure Drug Dudley JT, Sirota M, ..., Pasricha J, Butte AJ. Science Translational Medicine, 2011. Psychiatric Drug Imipramine Shows Significant Activity Against Small Cell Lung Cancer p53/Rb/p130 triple knockout Mazen Nasrallah model of SCLC Peter Marinkovich Mårten Winge Mice dosed after tumor formation Joel Dudley Nadine Jahchan Julien Sage Alejandro Sweet‐Cordero Joel Neal Vehicle control Imipramine NuMedii Unpublished October 4, 2015 4 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Company launched, Claremont Creek, Need more drugs Public big data Data analyzed, ARRA, StartX, NIH funding Lightspeed ($3.5 for more diseases available method designed Stanford license, million) first deal Unpublished Credit: Whitehead Institute and MIT Credit: Oxford Nanopore Technologies and Wired Credit: Euan Ashley, Russ Altman, Steve Quake, Lancet October 4, 2015 5 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Human genome sequence can be used to predict drug adverse events Important genome differences “locked up” in publications Credit: Russ Altman and team Credit: Rong Chen, Optra Systems, and Personalis, Inc. Collect the “big data” of findings across publications to analyze the “big data” of the genome Credit: Rong Chen, Optra Systems, and Personalis, Inc. Credit: Rong Chen, Optra Systems, and Personalis, Inc. Credit: Rong Chen, Optra Systems, and Personalis, Inc. Credit: Rong Chen and Alex Morgan, Lancet October 4, 2015 6 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Maybe the genome can be used to suggest (promote?) preventative health strategies? Credit: Rong Chen, Alex Morgan, Joel Dudley, Lancet Credit: Rong Chen, Alex Morgan, Joel Dudley, Lancet Nicholas Volker Credit: Rong Chen, Alex Morgan, Joel Dudley, Lancet Future blood tests will be performed in non‐traditional outlets. With daily Where will the data live? weight and intake measures, I have lost 50 pounds (22 kg) in the past 2 years! October 4, 2015 7 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Medical devices can be funded and designed by internet technologists! Where will the data live? Public data can drive health defining mobile apps The cost of delivered care is becoming public. How will the public respond? immport.niaid.nih.gov The next big open data? Raw clinical trials data Download 100+ studies today Jeff Wiser Patrick Dunn Sanchita Bhattacharya October 4, 2015 8 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Institute for Computational Health Sciences How can we expect health care professionals to review 6 billion pieces of data in a 15 minute encounter? We already ask We already ask health care health care professionals professionals to review 1 GB of to review 1 GB of data in 15 data in 15 minutes… minutes… What is Big Data in Biomedicine? We already ask health care professionals to review 1 GB of data in 15 minutes… … but we give them tools to help them do this! October 4, 2015 9 Using a Trillion Points of Data to Deliver Precision Medicine Atul Butte, MD, PhD Big Data in Biomedicine is… Big Data in Biomedicine is… Algorithms? Predicting the disease before it strikes Programmers? Explaining the rare disease that defies experts Databases? Finding drugs for diseases lacking attention High‐performance computers? Making sure we do the right thing for patients Mobile? An amazing platform for biomedical innovation Collaborators •Jeff Wiser, Patrick Dunn, Mike Atassi / Northrop Grumman Big Data in Biomedicine is •Ashley Xia and Quan Chen / NIAID • Takashi Kadowaki, Momoko Horikoshi, Kazuo Hara, Hiroshi Ohtsu / U Tokyo •Kyoko Toda, Satoru Yamada, Junichiro Irie / Kitasato Univ and Hospital •Shiro Maeda / RIKEN • Alejandro Sweet‐Cordero, Julien Sage / Pediatric Oncology •Mark Davis, C. Garrison Fathman / Immunology •Russ Altman, Steve Quake / Bioengineering •Euan Ashley, Joseph Wu, Tom Quertermous / Cardiology Hope •Mike Snyder, Carlos Bustamante, Anne Brunet / Genetics •Jay Pasricha / Gastroenterology •Rob Tibshirani, Brad Efron / Statistics • Hannah Valantine, Kiran Khush/ Cardiology •Ken Weinberg / Pediatric Stem Cell Therapeutics •Mark Musen, Nigam Shah / National Center for Biomedical Ontology • Minnie Sarwal / Nephrology •David Miklos / Oncology Support • Lucile Packard Foundation for Children's Health •NIH: NIAID, NLM, NIGMS, NCI; NIDDK, NHGRI, NIA, NHLBI, NCATS •March of Dimes •Hewlett Packard •Howard Hughes Medical Institute • California Institute for Regenerative Medicine •Luke Evnin and Deann Wright (Scleroderma Research Foundation) • Clayville Research Fund • PhRMA Foundation Admin and Tech Staff •Stanford Cancer Center, Bio‐X, SPARK •Mary Lyall • Mounira Kenaani •Kevin Kaier • Tarangini Deshpande •Boris Oskotsky •Sam Hawgood •Keith Yamamoto • Isaac Kohane October 4, 2015 10.
Load more

Recommended publications
  • 2013-Boston-MA
    International Workshop on Scleroderma Research Under the aegis of: 13th I N T E R N A T I O N A L W O R K S H O P on S C L E R O D E R M A R E S E A R C H NIAMS Scleroderma Center of Research Translation, Boston University School of Medicine August 3rd – 7th, 2013 Boston, Massachusetts Centre for Rheumatology and Connective Tissue Disorders University College London (Royal Free Hospital Campus) Organizers Co-chairs Professor Dame Carol Black Professor Robert Lafyatis Organizing Committee Professors David Abraham, Christopher Denton, Carol Feghali-Bostwick, Armando Gabrielli, Thomas Krieg, Luc Mouthon, Marlene Rabinovitch, Kristofer Rubin, Maria Trojanowska, John Varga, Michael Whitfield. Coordinators Kate Brennan, Kim Fligelstone, Millie Williams, Pamela Yeomans www.bumc.bu.edu/sclerodermaworkshop A c k n o w l e d g e m e n t s The organizers would like to thank the following for their support of the Workshop: GOLD LEVEL SPONSORS SILVER LEVEL SPONSOR BRONZE LEVEL SPONSORS Other Contributors 13th International Workshop on Scleroderma Research Boston University ~ Boston, Massachusetts ~ August 3-7, 2013 W o r k s h o p I n f o r m a t i o n Conference Office (10) Dinner Banquet (39) 10 Buick Street, G-18 Metcalf Trustee Center Ballroom, One Silber th Opening times: Way, 9 Floor Tuesday, August 3rd, 6-9pm Saturday 1pm-5pm Sunday 8am-3pm Getting to the Banquet: Mon-Wed 8am-5pm Shuttle (Free): The Boston University Shuttle leaves from in front of 33 Harry Agganis Way at 5:30pm & 5:45pm and arrives at the corner Accommodations (10) of Blandford Street and Commonwealth in 10 Buick Street about 6 minutes.
    [Show full text]
  • Viewed 10,954 Hospital Cios Across 32 Administrative Regions in Mainland China
    JMIR Medical Informatics Clinical informatics, decision support for health professionals, electronic health records, and eHealth infrastructures Volume 8 (2020), Issue 2 ISSN: 2291-9694 Contents Original Papers Evaluating the Applications of Health Information Technologies in China During the Past 11 Years: Consecutive Survey Data Analysis (e17006) Jun Liang, Ying Li, Zhongan Zhang, Dongxia Shen, Jie Xu, Gang Yu, Siqi Dai, Fangmin Ge, Jianbo Lei. 3 Intellectual Structure and Evolutionary Trends of Precision Medicine Research: Coword Analysis (e11287) Xiaoguang Lyu, Jiming Hu, Weiguo Dong, Xin Xu. 19 Analyzing Medical Research Results Based on Synthetic Data and Their Relation to Real Data Results: Systematic Comparison From Five Observational Studies (e16492) Anat Reiner Benaim, Ronit Almog, Yuri Gorelik, Irit Hochberg, Laila Nassar, Tanya Mashiach, Mogher Khamaisi, Yael Lurie, Zaher Azzam, Johad Khoury, Daniel Kurnik, Rafael Beyar. 39 Detection of Postictal Generalized Electroencephalogram Suppression: Random Forest Approach (e17061) Xiaojin Li, Shiqiang Tao, Shirin Jamal-Omidi, Yan Huang, Samden Lhatoo, Guo-Qiang Zhang, Licong Cui. 53 The Impact of Electronic Health Records on the Duration of Patients'Visits:Time and Motion Study (e16502) Abdulrahman Jabour. 64 Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison (e14777) Caitrin McDonough, Steven Smith, Rhonda Cooper-DeHoff, William Hogan. 73 Evaluation of Privacy Risks of Patients' Data in China: Case Study (e13046) Mengchun Gong, Shuang Wang, Lezi Wang, Chao Liu, Jianyang Wang, Qiang Guo, Hao Zheng, Kang Xie, Chenghong Wang, Zhouguang Hui. 85 Identifying Acute Low Back Pain Episodes in Primary Care Practice From Clinical Notes: Observational Study (e16878) Riccardo Miotto, Bethany Percha, Benjamin Glicksberg, Hao-Chih Lee, Lisanne Cruz, Joel Dudley, Ismail Nabeel.
    [Show full text]
  • Report on the California Initiative to Advance Precision Medicine to the California Legislature January 2018
    Report on the California Initiative to Advance Precision Medicine to the California Legislature January 2018 1 California Initiative to Advance Precision Medicine Report to the State of California Legislature January 2018 Report prepared by The Governor’s Office of Planning and Research in collaboration with University of California, San Francisco pursuant to Chapter 1.5 of Division 1 of Title 7 of the Government Code Ken Alex, JD Director, Governor’s Office of Planning and Research; Senior Advisor, Office of Governor Edmund G. Brown Jr. Lark Park Senior Advisor, Office of Governor Edmund G. Brown Jr. Elizabeth Baca, MD, MPA Senior Health Advisor, Governor’s Office of Planning and Research Atul Butte, MD, PhD Principal Investigator, California Initiative to Advance Precision Medicine; Director, Institute for Computational Health Sciences; Distinguished Professor of Pediatrics, University of California, San Francisco India Hook-Barnard, PhD Executive Director, California Initiative to Advance Precision Medicine Director of Research Strategy; Associate Director, Precision Medicine, University of California, San Francisco Uta Grieshammer, PhD Scientific Officer, California Initiative to Advance Precision Medicine Governor’s Office of Planning and Research 1400 Tenth Street Sacramento, California 95814 Phone: (916) 322-2318 2 Table of Contents I) Executive Summary II) Background A) What is Precision Medicine? B) Brief History of CIAPM III) CIAPM Allocation of Funds A) Allocation of Supplemental Funds from FY 2016-17 Budget B) Allocation of Funds from FY 2017-18 Budget IV) Program Highlights A) Demonstration Projects B) Precision Medicine Assets C) Economic Impact Analysis D) Convenings V) Advisory Committee VI) Impact Beyond CIAPM VII) Conclusion 3 I.
    [Show full text]
  • ITI HUMAN IMMUNE MONITORING TECHNOLOGY and BIOINFORMATICS CONFERENCE – MARCH 30-31, 2018 Speakers Bios
    ITI HUMAN IMMUNE MONITORING TECHNOLOGY AND BIOINFORMATICS CONFERENCE – MARCH 30-31, 2018 Speakers Bios Robert Michael Angelo, MD, PhD Mike Angelo is an assistant professor of Pathology and Member of the Child Heath Research Institute and Cancer Institute at Stanford. He received his BS in Physics at the University of Mississippi. From 2002-2010, he was enrolled at Duke University in the Medical Scientist Training Program where he completed an MD and a PhD with an emphasis in biochemistry and electrical engineering. His experience in systems development led to a broader interest in clinical diagnostics, and ultimately a residency in clinical pathology at University of California San Francisco (2010- 2013). During that time, he became interested in developing novel methods for immunohistochemical multiplexing using mass spectrometry, which led him to the Nolan Lab at Stanford University. He developed a completely new method for simultaneous imaging of up to 100 metal-labeled antibodies within a single tissue section using multiplexed ion beam imaging (MIBI). Dr. Angelo is interested in optimizing this and other mass reporter based technologies further with the goal of identifying new transcriptional and translational signatures in solid tissue malignancies that can be used to improve clinical diagnosis and treatment. https://med.stanford.edu/profiles/robert-angelo Nima Aghaeepour, PhD Dr. Aghaeepour completed his undergraduate studies Computer Science at the University of Tehran were he helped create a soccer team of robots. His graduate research at University of British Columbia with Ryan Brinkman and Holger Hoos focused on bioinformatics analysis of single cell data. He established the first objective benchmark for evaluation of algorithms that could automatically identify cell-types (and, eventually, correlate them with clinical outcomes), namely the Flow Cytometry: Critical Assessment of Population Identification Methods (Flow- CAP).
    [Show full text]
  • Purvesh Khatri CV 8 External
    Purvesh Khatri 1265 Welch Rd. X219 Medical School Office Building Stanford, CA 94305 Email: [email protected] Phone: (650) 497 5281 Academic Appointments 2018 Associate Professor (May 1, 2018 – Present) Stanford Institute for Immunity, Transplant and Infection Center for Biomedical Informatics Research Department of Medicine, Stanford University 2014 Assistant Professor (October 1, 2014 – April 30, 2018) Stanford Institute for Immunity, Transplant and Infection Center for Biomedical Informatics Research Department of Medicine, Stanford University 2013 Acting Assistant Professor (April 1, 2013 – September 30, 2014) Stanford Institute for Immunity, Transplant and Infection Center for Biomedical Informatics Research Department of Medicine, Stanford University 2011 Research Associate (April 1, 2011 - March 31, 2013) Divisions of Systems Medicine and Nephrology Department of Pediatrics, Stanford University 2008 Postdoctoral Scholar (July 1, 2008 - March 31, 2011) Center for Biomedical Informatics Research (BMIR) Departments of Pediatrics and Medicine, Stanford University 2008 Part-time Faculty (January 2008 - April 2008) Department of Computer Science, Wayne State University 2006 Postdoctoral Fellow (August 2006 - June 2008) Intelligent Systems and Bioinformatics Laboratory Department of Computer Science, Wayne State University 2000 Research Assistant (July 2000 - August 2006) Intelligent Systems and Bioinformatics Laboratory Department of Computer Science, Wayne State University 2003 Research Scientist (January 2003 - June 2004) Bioinformatics cell, Telemedicine and Advanced Technology Research Center, US Army Medical Research and Materiel Command 2002 Teaching Assistant (August 2002 - December 2002) Department of Computer Science, Wayne State University 2000 Research Assistant (July 2000 - August 2002) Center for Molecular Medicine and Genetics, Wayne State University Education 2006 Ph.D. in Computer Science Wayne State University, Detroit, MI Thesis: Onto-Tools: Tools for Functional Design and Interpretation of High Throughput Gene Expression Data 2006 M.S.
    [Show full text]
  • Translational Informatics of Population Health: How Large Biomolecular and Clinical Datasets Unite
    Pacific Symposium on Biocomputing 2019 Translational informatics of population health: How large biomolecular and clinical datasets unite Yves A. Lussier, MD Center for Biomedical Informatics & Biostatistics, Department of Medicine, BIO5 Institute, Cancer Center, The University of Arizona 1230 North Cherry Avenue, Tucson, AZ 85721 [email protected] Atul J. Butte, MD, PhD Bakar Computational Health Sciences Institute, University of California, San Francisco 550 16th Street, San Francisco, CA 94158 [email protected] Haiquan Li, PhD College of Agriculture and Life Sciences, The University of Arizona 1177 E 4th Street, Shantz 509, Tucson, AZ 85719 [email protected] Rong Chen, PhD Sema4 Genomics 333 Ludlow Street, Stamford, CT 06902 [email protected] Jason H. Moore, PhD The Perelman School of Medicine, University of Pennsylvania D202 Richards, 3700 Hamilton Walk, Philadelphia, PA 19104 [email protected] This paper summarizes the workshop content on how the integration of large biomolecular and clinical datasets can enhance the field of population health via translational informatics. Large volumes of data present diverse challenges for existing informatics technology, in terms of computational efficiency, modeling effectiveness, statistical computing, discovery algorithms, and heterogeneous data integration. While accumulating large ‘omics measurements on subjects linked with their electronic record remains a challenge, this workshop focuses on non-trivial linkages between large clinical and biomolecular datasets. For example, exposures and clinical datasets can relate through zip codes, while comorbidities and shared molecular mechanisms can relate diseases. Workshop presenters will discuss various methods developed in their respective labs/organizations to overcome the difficulties of combining together such large complex datasets and knowledge to enable the translation to clinical practice for improving health outcomes.
    [Show full text]
  • Data Deluge Mastering Medicine’S Tidal Wave
    STANFORDS T A MEDICINEM E D Summer 2012 special report DATA DELUGE MASTERING MEDICINE’S TIDAL WAVE Dig it The data miner Coming into its own Biostatistics is red hot Vernor Vinge The sci-fi author talks health care Mother lode Hospital records deliver the goods plus Playing doctor Gaming as a tool to save lives Cancer TKO An antibody that pulls no punches STANFORD MEDICINE Summer 2012 COUNT ON IT A NEW IMMUNE-SYSTEM SENSOR COULD SPEED UP DISEASE DETECTION Manish Butte wanted a better test for “bubble boy disease.” The weeks-long wait for the standard blood test results for the severe immune deficiency was too risky, leaving newborns vulnerable to life-threatening infections. • So Butte and his team invented a new medical sensor that could detect low T-cell counts, a hallmark of the congenital immune deficiency, in just 15 minutes. That’s great. But what’s even better is that the sensor is so versatile and inexpensive — the prototype cost just $60 to build — it could simplify diagnosis of a huge range of diseases. • Their device, called an integrated microfluidics-waveguide sensor, sorts and counts cells in small samples of blood and other body fluids. The thumbnail-sized sensor measures different types of white blood cells, a key component of the immune system, and could be used in doctors’ offices, newborn nurseries, patients’ homes, disaster sites and battlefields. “Catching infections early is important for many patient populations,” says Butte, MD, PhD. He is an assistant professor of pediatrics at Stanford, a pediatric immunologist at Lucile Packard Children’s Hospital and the senior author of a paper describing the sensor that appeared in March in Biomicrofluidics.
    [Show full text]
  • Precision Medicine: an Action Plan for California
    Precision Medicine: An Action Plan for California Precision medicine – which encompasses our ability to harness all available data and technology tools at our disposal to prevent and treat human illness and improve human health – is a tremendous opportunity. Map of Scientific Connections Computed by Olivier H. Beauchesne and SCImago Lab, data by Elsevier Scopus This page has intentionally been left blank. Acknowledgements Members Arnold Milstein, MD, MPH Frederick J. Meyers, MD Hakan Sakul, MS, PhD Jay Gellert Jessica Mega, MD, MPH Jill P. Mesirov, PhD, MA John Carpten, PhD Kim Goodwin Lisa Suennen Mary E. Maxon, PhD Michael Milken Sol Lizerbram, DO Stephen H. Lockhart, MD, MPhil, PhD Tomás J. Aragón, MD, MPH, DrPH Co-Chairs Kelsey Martin, MD, PhD Atul Butte, MD, PhD Additional Support Staff Clara Lajonchere, PhD Geoffrey Moore India Hook-Barnard, PhD Oliver Keown, MD Governor’s Office of Planning and Research Elizabeth Baca, MD, MPA Lark Park Beth Hotchkiss Tristan Stein Denise Gutierrez The Precision Medicine Advisory Committee created this report based on countless discussions, expert presentations, public forums, and review of peer-reviewed literature. The committee would like to extend gratitude to a number of people who informed their thinking for this report. A special thank you to: Attendees at the public forums Amy Tong Calum MacRae Camille Nebeker Claudia Williams Deb Kilpatrick Deven McGraw Genya Dana Hal Yee Ira Mellman Jesse Torres John Wilbanks Khaled Sarour Karol Watson Keith Yamamoto Kirsten Bibbins-Domingo Manoja Lecamwasam Marilyn Tavenner Mark Williams Max Bronstein Micah Weinberg Nazneen Aziz Patricia Cooper Scott Christman Tanisha Carino Wendy Benson Ysabel Duron Letter to the Governor December 26, 2018 The Honorable Edmund G.
    [Show full text]
  • Harnessing the Power of Big Data in Precision Medicine
    March 13–14, 2018 Hotel Kabuki, San Francisco, CA PRE-CONFERENCE WORKSHOP DAY March 12, 2018 NASA Ames Research Center Mountain View, CA HARNESSING THE POWER OF BIG DATA IN PRECISION MEDICINE Bought to you by: In conjunction with: http://www.terrapinn.com/biodatawest OUR STORY Atul Butte Director, Institute for In 2017, we held the inaugural BioData West, with an incredible speaker faculty transferring bleeding edge Computational Health technology into pharmaceutical development and healthcare. The event featured presentations from the Sciences, AI likes of Jeff Dean, Senior Fellow, Google - Google’s 20th employee and co-founder at Google Brain, Atul University of California, Butte, Director, Institute for Computational Health Science, UCSF and John Mattison, the Chief Medical San Francisco Information Officer and Assistant Medical Director for Kaiser Permanente. PRECISION The revolutionary AI stream of the event was initially commissioned by Merck in order to implement a global MEDICINE AI strategy and live-streamed to their executive board. This year we are working alongside Roche to drive game changing technologies in drug development and healthcare. HEALTH We are pleased to announce a partnership with NASA for 2018. Due to a federal partnership seeded between NASA and the NCI (National Cancer Institute) along with a pre-conference workshop taking SYSTEMS place at NASA on March 12th. These sessions are designed to bring together the world’s thought leaders and learn about new sources of data and collaboration with an open mind. Vikram Bajaj Co- Founder, Google James Dzierzanowski Life Sciences, Former Our partners include Roche, American Heart Association, GSK, NCI, NASA, Google, Merck, CLSA, UCSF Executive Director, CSO, GRAIL, Managing Kaiser Permanente and D-Wave amongst others.
    [Show full text]
  • BCRP Brochure 2019-20
    Boston Combined Residency Program The Pediatric Residency Training Program of Boston Children’s Hospital Harvard Medical School and Boston Medical Center Boston University School of Medicine Aug 2019 edi,on CLASS OF 2020.. BOSTON COMBINED RESIDENCY PROGRAM Boston Medical Center Boston Children’s Hospital CONTENTS History…………........................... 3 Rotation " descriptions.................. 47" Global health grants………….… 82 " BCRP…........................................ 3" Night call................................... 53" Global health picture gallery….. 83" Boston Children’s Hospital........... 3" Longitudinal ambulatory.............. 54" Diversity and Inclusion................. 85" Boston Medical Center................. 8" Electives………………………….. 55" Some URM faculty..................... 86" People……................................... 11 Individualized curriculum............ 56" Salaries and benefits.................... 88" Program director biosketches...... 11" Academic development block.. 56" Child care................................... 89" Residency program leadership..... 12" Education.................................... 57" O$ce of fellowship training....... 89" Interns and residents.................... 13" Conferences.............................. 58" Cost of living............................... 90" Interns......................................... 13" Resident as teacher.................. 60" After hours.................................. 93 Junior residents.......................... 16" Simulators……………………… 60" With colleagues...........................
    [Show full text]
  • Module Intro Functional Genomics
    Discovering new drugs and diagnostics from 300 trillion points of data Atul Butte, MD, PhD [email protected] Chief, Division of Systems Medicine, @atulbutte Department of Pediatrics, @ImmPortDB Department of Medicine, and, by courtesy, Computer Science Center for Pediatric Bioinformatics, LPCH Stanford University Disclosures • Scientific founder and – Geisinger advisory board membership • Honoraria – Genstruct – Lilly – NuMedii – Pfizer – Personalis – Siemens – Carmenta – Bristol Myers Squibb • Past or present consultancy • Speakers’ bureau – Lilly – None – Johnson and Johnson • Companies started by students – Roche – Carmenta – NuMedii – Serendipity – Genstruct – NuMedii – Tercica – Stimulomics – Ansh Labs – NunaHealth – Prevendia – Praedicat – Samsung – Flipora – Assay Depot – Regeneron – Verinata Kilo Kilo Mega Kilo Mega Giga Kilo Mega Giga Tera Kilo Mega Giga Tera Peta Kilo Mega Giga Tera Peta Exa Kilo Mega Giga Tera Peta Exa Zetta Total 1.2 million microarrays available Doubles every 2-3 years Butte AJ. Translational Bioinformatics: coming of age. JAMIA, 2008. 92 million substances x 600,000 assays 1 billion points of data within a grid of 10 trillion cells Validation methods are increasingly commoditized Marina Sirota Joel Dudley Lamb J, ..., Golub TR. Science, 2006. Sirota M, Dudley JT, ..., Sweet-Cordero A, Sage J, Butte AJ. Science Translational Medicine, 2011. Anti-seizure drug works against a rat model of inflammatory bowel disease Marina Sirota Joel Dudley Mohan M Shenoy Dudley JT, Sirota M, ..., Pasricha J, Butte AJ. Science Translational Medicine, 2011. Jay Pasricha Anti-seizure drug works against a rat model of inflammatory bowel disease Rat colonoscopy Rat with Inflammatory Inflammatory Bowel Disease Bowel Disease After Anti-seizure Drug Dudley JT, Sirota M, ..., Pasricha J, Butte AJ.
    [Show full text]